• BGF Investment Management completed a follow-on investment as part of a USD 19 million private funding round for TidalSense.
• TidalSense is a Cambridge-based respiratory diagnostics company using AI to detect COPD from a 75-second normal-breathing test on a handheld device.
• Proceeds target UK, Ireland, and broader European commercialization, with expansion plans for entry into the US market.
• BGF first invested in TidalSense in December 2020, with multiple follow-on investments since to support growth.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BGF Investment Management Ltd published the original content used to generate this news brief on July 24, 2026, and is solely responsible for the information contained therein.